Introduction
Glaucoma is a potentially devastating disease of the eye that affects mainly people over 40 years of age. It is, after cataract, the leading cause of blindness in the world affecting approximately 70 million people. 1, 2 The only available treatment for glaucoma, short of surgery, is nonspecific, and involves the daily application of eye drops. Glaucoma, characterized by the degeneration of retinal ganglion cells associated with cupping of the optic nerve head, is in most cases the result of an elevated intraocular pressure.
increasing or decreasing the expression of relevant trabecular meshwork genes, we could potentially lower the resistance to the aqueous humor flow. In vivo gene therapy of the TM would present the clear advantage that, because of the natural direction of the flow, vectors administered to the anterior chamber would be directly delivered to the cells of the TM. Gene transfer vectors, besides being able to express their genes in non-proliferating cells, would also need to fulfill the criterion of minimal interference with the delicate flow system of the aqueous humor. Viral vectors will be favored versus nonviral ones because of potential occlusion of the outflow pathway by DNA precipitates or lipid complexes.
Adenoviral vectors have proven to be very effective in transferring genes to nondividing cells [10] [11] [12] [13] and for this reason have became the vectors of choice for gene transfer to the eye. [14] [15] [16] [17] [18] [19] Previous experiments from our laboratory have shown that a single injection into the anterior chamber of rabbits resulted in effective gene transfer into the cells of the trabecular meshwork. 14 We further show that, at concentrations of 10 8 particle forming units (p.f.u.), gene transfer also occurred to the anterior segment organ culture from human donors. 20 In this study, we extended gene transfer evaluations into the intact human trabecular meshwork to the use of lower adenoviral concentrations. Most importantly, we assessed the potential of gene therapy for glaucoma by using models that monitor changes in outflow facility (C = flow/pressure). We used four different adenoviral vectors in two such perfusion models: a constant press-ure, short-term, whole enucleated eye porcine model and a constant flow, long-term, perfused human anterior segment organ culture. We observed that positive gene transfer occurred at concentrations of adenoviral vectors that did not appear to interfere with the flow of the aqueous humor through the trabecular meshwork. These results indicate that gene therapy could also be conceived as an attractive future treatment for glaucoma.
Results
Gene transfer into human anterior segment perfused organ culture Anterior segment cultures from 31 pairs of post-mortem human donor eyes were perfused under conditions emulating the natural flow of aqueous humor and evaluated for gene transfer (see Materials and methods). In whole tissue mounts, injection of the anterior segments with Ad.Pac␤-Gal at 10 8 (11 pairs), 10 7 (two pairs), 10 6 (nine pairs) and 10 5 (nine pairs) resulted in high level transgene expression in all tissues exposed to the virus-infected medium ( Figure 1 ). Trabecular meshwork, ciliary body, corneal endothelium and sclera showed positive staining while none of the vehicle injected ones showed any transferred enzyme activity ( Figure 1 ). When observed in whole mounts, the general staining intensity of the tissue appeared to diminish with viral concentration, especially in the corneal endothelium.
Histological results are presented in Figure 2 . Though a slight variation to viral response was observed among individual specimens, all layers of the trabecular meshwork: uveal, corneoscleral, juxtacanalicular (JCT) and inner wall of the Schlemm's canal (SC) are transduced with the foreign reporter gene. Staining appears to be heavier in the corneoscleral (beam region) and JCT, while cells of the inner wall of the SC are less frequently Effects of recombinant adenovirus on the outflow facility of perfused whole enucleated porcine eyes In order to investigate the physiological effect of the physical viral particle in outflow facility, we performed perfusions for a short period of time (5.5 h). Figure 3 shows the hourly changes in outflow facility caused by the different viral treatments. Control eyes in this perfusion model show a gradual increase of outflow with time, a phenomena that has been described in the literature as 'washout'. 21, 22 The effect of intracameral injection on the outflow facility was analyzed by measuring the C of all the pooled vehicle-injected eyes and comparing it with that of the perfused noninjected eyes. Result values of 21% ± 2% (n = 16) versus 19% ± 2% (n = 32) indicated that no detrimental effect in facility was due to the injection (Figure 3a) . and AdCL, 24 (total n = 12) showed, after 4 h, an increase in outflow facility of 8% ± 3% versus a 21% ± 4% increase in outflow in paired control eyes (Figure 3b ). If calculated as separate groups, at 4 h, Av1LacZ4 (n = 3) caused an increase of 8% ± 8% versus an increase of 21% ± 3% in the paired control; Av1Luc1 (n = 4) caused an increase 3% ± 2 versus an increase of 16% ± 3% in the paired controls and AdCl (n = 5) induced an increase of 13% × 6 versus an increase of 25% ± 10% in the paired controls. Perfusions were also performed with 10× lower concentrations (1-5 × 10 7 p.f.u.) of the above viral stocks of Av1LacZ4 and Av1Luc1. This lower viral concentration showed an increased outflow of 17% ± 4% compared with the 19% ± 4% increase in outflow observed in paired control eyes at 4 h (n = 13, Figure 3c ). Calculated in separate groups, Av1LacZ4 (n = 7) resulted in an increase of 22% ± 5% versus 20% ± 5% increase observed in the paired control. Interestingly, Av1Luc1 (n = 6) caused a smaller increase in outflow, 9% ± 6% compared with the 18% ± 6% of the contralateral eyes. At both concentrations, Av1Luc1 appears to cause a greater reduction in facility than Av1LacZ4, indicating a possible effect of the different viral concentration of these viral stocks.
As positive and negative controls, two drugs known to either decrease or increase outflow respectively, were added to the study. Four hours after p-chloromercuribenzene sulfonate (PCMBS) treatment (10 mm) (n = 4) caused the expected decrease in outflow facility of 53% ± 12% 
Outflow facility measurements of perfused human organ cultures after recombinant viral injection
The baseline outflow facility values of experiments performed at constant flow show some variation among the pairs of eyes from individual donors and occasionally, between eyes from the same pair. In this study the average facility at baseline of all the injected eyes was calculated to be 0.209 ± 0.024 (n = 27).
Experiments were performed with paired eyes. Organ cultures of human anterior segments injected with a single dose of 20 l containing 10 8 p.f.u. of Ad.Pac␤-Gal exhibited a temporary 54% ± 4% reduction in outflow facility (C) from the baseline C 0 (n = 6) ( Figure 4 ). The declining effect appeared within 2 h after injection, peaked at 12 h and quickly started recovering after that time. Complete recovery to baseline levels occurred at about 36 h after infection, with a C 36 /C 0 value of 1.00 ± 0.13. At doses of 10 5 (n = 6), no significant effect on change of outflow facility was observed and at 48 h, C 48 /C 0 values were 0.94 ± 0.06 ( Figure 4 ). The facility of outflow of the contralateral eyes from the 10 8 set (n = 5), injected with 20 l of viral vehicle caused a 15% ± 6% decrease at 42 h (n = 5) and a 16% ± 7% at 48 h (n = 4) with one anterior segment not included in the calculations because of abnormal facilities. The facility of outflow of the contralateral eyes from the 10 5 set (n = 4), resulted in 8% ± 10% increase at 42 h and a 14% ± 16% at 48 h with two anterior segments not included p.f.u. did not cause any reduction in outflow facility in their experimental eye as compared with their baseline values (not shown). All anterior segments used in the outflow facility study were assayed for ␤-gal activity at the end of the experiment. All infected cultures were positive while all vehicle injected ones were negative.
Figure 3 Effect of adenovirus on the facility of outflow of whole enucleated porcine eyes perfused at constant pressure. Outflow facility was calculated as the recorded changes of flow divided by the constant pressure. Percent changes are calculated from baseline values obtained before injections (see Materials and methods). (a) Single injections of vehicle and sham manipulation. At 4 h, the vehicle showed no change in facility versus the sham manipulated control (21% ± 2% versus 19% ± 3%) (n = 32). (b) Single injections of 10 8 adenovirus and vehicle. At 4 h, the virus showed a reduction in facility versus the vehicle injected control (8% ± 3% versus 21% ± 4%) (n = 12). (c) Single injections of 10 7 adenovirus and vehicle. At 4 h, the virus showed no change in facility versus the vehicle injected control (17% ± 4% versus 19% ± 4%) (n = 13). (d) Anterior chamber exchange of 10 mm PCMBS and control. At 4 h, PCMBS showed a reduction in facility versus
Viral vector route on the aqueous humor outflow pathway of porcine eyes During the normal life cycle of adenovirus, the particle infects the cells through a two-step process using a receptor for attaching to cells and a second receptor (integrins) for internalization. [25] [26] [27] Inside the cells, the virus enters the nucleus and starts transcribing its DNA right away. 28 The perfusion model of whole enucleated porcine eyes lasts for only 4 h after viral injection and accumulation of the delivered protein may be low. To investigate the behavior of the physical particle through the outflow pathway during perfusion conditions and, at the same time, confirm the presence of the virus in the porcine eyes, we chose to do an electron microscopy evaluation of their trabecular meshwork. The whole eye was fixed by sequential fixation of perfusion and immersion as indicated in Materials and methods.
Adenoviral particles were identified in all the infected specimens examined ( (Figure 5b ). Occasionally, they were detected close to the nuclear membrane and inside the nucleus as those shown in the corneoscleral cell of Figure 5d . All the virus observed were in close association with the cells and none was detected trapped in between the extracellular matrix.
Discussion
We have conducted an in-depth evaluation of the potential use of adenoviral gene therapy to treat glaucoma. The disease can result in blindness, is highly prevalent in the older population and the only drugs available are nonspecific and have only a short term effect. Gene therapy could provide an important advantage in treatment.
The experiments performed to assess positive delivery of a reporter gene showed that the trabecular meshwork is a very active tissue for gene transfer. Under perfusion conditions, gene transfer to the trabecular meshwork is also extremely reliable. The 31 pairs of post-mortem human eyes used in this study had a quite broad origin regarding age, sex, race and geographical location. Nonetheless, 100% of them, including the pair from the oldest donor (95 years old) exhibited positive gene transfer. The eight pairs studied histologically revealed that the virus does not appear to damage the architecture of the tissue nor the shape of the cells. Though detailed morphometry was not performed, no obvious cell loss was apparent. We also observed that the cells of the JCT and SC are very efficiently transduced. This finding is important for potential outflow regulation. Grant, Mäepea and Bill [29] [30] [31] [32] [33] have localized the site of both normal aqueous humor resistance and the abnormal outflow resistance in glaucoma, to be deep into the TM, in the JCT layer and/or inner wall of the SC.
The concentration of the virus did not seem to affect significantly the total number of outflow pathway cells stained, indicating perhaps a variation in the number of metabolically active cells present in each human donor eye. Concentration of the virus did seem however, to have an effect on the distribution of the positive cells. At 10 8 concentration, gene transfer seems to go deeper into the tissue than at 10 5 concentration and cells of the outer wall of the SC are more often stained at the higher concentration. Curiously, at 10 8 positive cells seem to follow preferentially a path that goes from the anterior nonfiltering TM tissue to SC, while at 10 5 they seem to reach SC mainly through the posterior TM. Clinical observations and experimental evidence on enucleated eyes indicate that very little filtration occurs through the anterior third of the trabecular meshwork. 30, 34 Though our experiments were directed to analyze the trabecular meshwork, we observed that corneal endothelium cells were also transduced. The swollen and detached endothelial cells seen in some of the higher concentration-injected tissues could indicate that these cells are more sensitive to such an overexpression of a foreign protein. We reported a similar observation when living rabbits were injected intracamerally with 10 8 p.f.u. of Av1LacZ4, 14 but not when rabbits were injected at lower concentrations (unpublished). In ex vivo cornea culture studies from humans, rabbits or rats, 18, 19, 35 where lower concentrations were used, the authors did not observe swelling or detachment. Although their cultures were not infected under perfusion pressure, treated corneas were able to keep corneal clarity after transplantation in rabbits. 19 Experiments measuring the effect of the viral vector on the outflow facility of porcine and human eyes showed comparable results. In the constant pressure, short-term, porcine perfusion model, injection of high concentrations of particles causes a reduction in outflow facility, a trend also seen when considering the effect of the individual viral stocks. In the constant flow, long-term, human anterior segment model, high concentration of the virus provokes an immediate increase in pressure that peaks at 12 h and recovers to baseline levels at about 36 h. This intraocular pressure increase (reflecting an increased outflow resistance, R = 1/C) is not observed in eyes injected with lower concentrations of the virus or with vehicle.
The mechanisms responsible for this early and transient intraocular pressure spike are not known. It could be due to active foreign gene transcription that starts very soon after infection. In standard wild-type adenovirus infections, the E1A protein is detected 1 h after viral entry. 28 However, the number of cells expressing the reporter gene at 10 8 does not appear to be markedly different from the 10 5 and the latter did not provoke the pressure increase. It is also improbable that the size of the virus particle would be responsible for a physical blocking effect. A number of early studies showed that the flow pores in the outflow pathway are approximately 1 m in diameter. [36] [37] [38] More recently, microspheres of 0.18 m and 1.1 m diameter, perfused at concentrations of 3-5 × 10 5 and 3 × 10 3 per ml, were thought to be captured in the filtration system because of sticking to the tissue and not as a function of size. 39 In that study, no measurements of outflow facility were conducted. Here, we have used a particle that is smaller (90 nm diameter), in about 1000 × higher concentration (10 8 p.f.u.), and that, very likely, is stickier than microspheres, since adenovirus attaches avidly to trabecular meshwork cells. 20 It is possible that our observations at high concentration may simply reflect a combination of all these characteristics: a high number of viral particles, an elevated foreign gene expression and an increased stickiness.
Using electron microscopy, we were able to visualize the virus through the outflow pathways. It was interesting to note that all particles after 4 h perfusion remained in very close association with the cells and no particles were detected trapped in between the extracellular matrix. This could be due to a random physical trapping of the viral particle by the cell's multiple filopodia or to the existence of a virus-cell tropism that will direct virus particles to the cells. In either case, the fact of this observed close contact of the particles with the trabecular cells would represent an advantage for a viral gene transfer situation.
Altogether these results demonstrate that the TM cells are good targets to transduce candidate genes potentially involved in outflow regulation. Although at the present time, genes involved in regulating outflow facility have not been discovered, candidate genes for glaucoma have begun to become available. Recently, a gene coding for a new protein has been linked to 3% of patients with primary open angle glaucoma. 40 Because we demonstrated positive gene delivery to the JCT and SC cells, recombinant adenoviral vectors carrying these genes could also prove to be great tools for studying their involvement in outflow facility. Moreover, the ability of viral particles to enter the cells naturally and move through the pathway, makes viral recombinants the delivery system of choice in a situation where potential disturbances of the extracellular material might occlude the outflow pathway. Other delivery systems, like the DNA-liposome complex have been successfully used to transfer foreign genes to ocular tissues, 41 but effects on outflow facility have not been measured.
Finally, the use of perfused intact human anterior segments organ culture emerges as a unique way to study the molecular biology of the human trabecular meshwork. The impediment of obtaining fresh human tissue is circumvented by the possibility of 'reviving' the tissue by perfusing serum-free medium at physiological pressure. It was encouraging to find that, despite the individual variation of the eyes, the average value for outflow facility for all eyes perfused here was that of 0.209, a value similar to the one measured in living human beings.
In summary, adenoviral recombinant vectors, as tested by two distinct perfusion models, appear adequate candidates to be used in the development of gene therapy of glaucoma. Under conditions that maintain its original architecture and mimic aqueous humor flow, we have shown that a reporter gene can be transferred to the human trabecular meshwork. A remaining challenge at this point would be to determine if the change of expression of a gene in a few cells would be sufficient to modulate the physiology of the outflow pathway as has been shown to occur in other systems. 42 Experiments to test this hypothesis are in progress.
Materials and methods

Adenovirus vectors
For the human anterior segment organ culture, we used the recombinant adenovirus Ad.Pac ␤-gal, generously provided by Dr Sam George (Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA). 43 This viral vector is derived from the in340 mutant strain of Ad5, 44, 45 containing a duplicate E1a enhancer/viral packaging signal (Ad5 bp 194-351) at the 3′ end of the virus. The viral vector was further modified to include a nuclear localizing E. coli LacZ driven by the cytomegalovirus promoter and a 2749 bp deletion from the E 3 region.
For the perfusions of the fresh enucleated whole porcine eye, we used three different recombinants, each bearing a different gene. Av1LacZ4 and Av1Luc1 23 containing the ␤-galactosidase and luciferase gene, respectively, and both driven by the RSV promoter were provided by material transfer agreement between Genetic Therapy Inc (Gaithersburg, MD, USA) and Duke University. AdCL was constructed by one of us (SCE) and contains the human catalase gene driven by the adenovirus major late promoter. 24 High titer stock adenovirus were generated by infecting subconfluent 293 cells at a multiplicity of infection of 10, and twice banding to equilibrium density in CsCl. 46 Viral band was collected and desalted by chromatography through Sephadex G25 (NAP-5; Pharmacia Biotech, Piscataway, NJ, USA) equilibrated with 0.01 m Tris 8, 0.01 m MgCl 2 , 10% glycerol. Gel-filtered virus was stored in 100 l aliquots at −70°C until use. Purified stocks were titered by the agar overlay plaque assay in 293 cells as described.
14 Viral titers were typically between 1 to 5 × 10 10 p.f.u.
Perfused human anterior segment organ culture A total of 31 pairs of fresh, normal human eyes were obtained from The National Disease Research Interchange (NDRI), a nonprofit organization engaged in the procurement and distribution of human tissues and organs for biomedical research in the USA. Every pair of eyes has the signed consent of the patient and it follows the Tenets of the Declaration of Helsinki. Eyes were dissected within 30 to 40 h of death. The age of the donors was between 50 and 95 years and none of them had been diagnosed with glaucoma. The study followed the Tenets of the Declaration of Helsinki. Organ cultures were prepared as described in earlier techniques. 47, 48 Briefly, eyes were dissected at the equator and their lens, iris and vitreous removed. The anterior segment was then clamped to a two cannula, modified Petri dish and perfused at constant flow 49 with Dulbecco's modified Eagle's medium containing 100 U/ml penicillin, 100 g/ml streptomycin, 170 g/ml gentamicin and 250 g/ml amphotericin B (DMEM+). Cultures were maintained at 37°C, 5% CO 2 for a maximum of 5 days. Flow rates of 3 to 4.5 l per min were maintained constant in each case with a Harvard microinfusion pump. Intraocular pressures were continuously monitored with a pressure transducer connected to the dish's second cannula and recorded with an automated computerized system. Figures 6 and 7 summarized the basic features of this culture. Figure 6 shows a diagram of the modified Petri dish connected by cannulas to a syringe plus microinfusion pump on one side and to a pressure transducer on the other. Figure 7 shows a photograph of the actual chamber with an anterior human segment clamped to the dish by the help of a tight fitting plastic ring.
Adenovirus gene delivery to human organ cultures Eyes were perfused for an initial minimum of 24 h with standard medium to allow stabilization of the cultures outflow facility. Then, perfusion pumps were stopped, pressure allowed to go down to р5 mmHg and eyes injected with 20 l of the viral solution using a 50 l Hamilton syringe and a 1 cm beveled 30 G disposable needle. The injection was performed by inserting the needle through the cornea, pushing the plunger in very slowly and allowing a few moments before retrieving it. The dish was then rocked gently north-south, east-west, two-three times to obtain mixing of the sample inside the chamber. Pumps were restarted and perfusion continued for about 48 h after injection. Thirty-one pairs of eyes from human donors received the virus in one eye while the contralateral was injected with virus vehicle. Original viral stocks were diluted in viral vehicle and given at four different concentrations.
Enzyme histochemistry
Histological studies of the trabecular meshwork region were performed on at least two quadrants of each of two pairs from each concentration studied. Tissue was assayed for ␤-galactosidase activity as previously described.
14 Briefly, whole anterior segment specimens were fixed for 30 min in 1% paraformaldehyde containing 0.2% glutaraldehyde, 0.02% NP40 and 0.01% sodium deoxycholate. Fixed tissues were washed twice in PBS and incubated overnight in 1 mg/ml X-gal, 0.5 mm K 3 Fe(CN) 6 , 0.5 mm K 2 HFe(CN) 6, 1 mm MgCl 2 . After staining, tissues were washed again in PBS, postfixed in 4% paraformaldehyde for 30 min, washed, assessed for blue color and photographed. Two pairs from each viral concentration group were processed for histological studies. The anterior segments were cut into quadrants. From each of two quadrants (180°C apart), wedge-shaped specimens containing the angle region with the trabecular meshwork were cut and embedded in glycol methacrylate using the JB-4 embedding kit from Polysciences (Warrenton, PA, USA). Blocks were counterstained with eosin and hematoxylin and sectioned to 2 m. At least two sections from the each of the two quadrants of the processed eyes were analyzed by light microscopy for morphology of the tissue and for the appearance of the characteristic blue staining (positive ␤-galactosidase activity). Paraformaldehyde solutions were made in PBS, kept at 4°C, and discarded after 3 weeks.
Short-term perfusion of whole enucleated porcine eyes Porcine eyes were obtained from a local commercial abattoir, enucleated and perfused within 4 h of death. The constant pressure perfusion technique using Grant stainless steel corneal fitting has been described. [50] [51] [52] [53] Briefly, a 4 mm central corneal button was removed with a trephine, the anterior chamber washed and the opening sealed back with the Grant fitting connected to the perfusion reservoir. Radial iridotomies were performed to prevent artificial deepening of the chamber. Eyes were perfused at room temperature with Dulbecco's phosphate buffer containing 0.68 mm CaCl 2 (DPBS, Gibco BRL, Gaithersburg, MD, USA) plus 5.5 mm d-glucose at 15 mmHg constant pressure. Flow changes were recorded as weight loss from the perfusion reservoir. Baseline measurements were determined after the eye had been perfused for 1.5 h to achieve a steady state flow value. One eye was then injected with 20 l of the recombinant adenovirus while the paired eye was injected with virus vehicle serving as control. Injection into the anterior chamber was performed using a 50 l Hamilton syringe and a 1 cm 30 G needle by inserting the needle (bevel up) tangentially into the chamber at the limbus. Before injection, the height of the eyes was raised for a couple of minutes to reduce turgidity. Perfusion continued for 4 h longer under the same buffer and pressure conditions used before injection.
For the drug treatments, drugs were dissolved in perfusion medium at concentrations of 10 mm (PCMBS, Sigma, St Louis, MO, USA) and 50 m (vinblastine; Sigma). After baseline perfusion, the corneal fitting was removed and the anterior chamber medium replaced with the perfusion medium containing the drug. Fitting was replaced and perfusion continued for 4 h either with perfusion buffer (for PCMBS) or with the solution containing the drug (for vinblastine). Contralateral eyes, used as controls, were subjected to sham manipulations and perfused with buffer and drug vehicle. Outflow facility (C) was calculated from flow values obtained every hour and expressed as a mean ± standard error. Results are expressed as percent change of facility from the baseline.
Outflow facility measurements of the human organ cultures Pressure values were obtained from readings recorded just before injection (baseline) and every 6 h for a period of about 48 h. Outflow facility (C), also defined as the inverse of the resistance (R) (C = 1/R), was calculated as the rate of the flow (F) divided by the intraocular pressure, P (Goldmann's equation, C = F/P). It is measured in l/min/mmHg. Data from each experiment is calculated as percent change of facility from the baseline and results from each eye are combined into a group and expressed as the mean ± standard errors.
Electron microscopy
To preserve proper architecture of the tissue during the fixation procedure, eyes were fixed with 2% glutaraldehyde in serial steps. At the end of perfusion, the Grant fitting was removed, anterior chamber emptied and refilled with fixative. Fitting was then replaced, connected to a fixative reservoir and eyes were perfused for 1 h at a pressure of 15 mmHg. Fixation was finished by tissue immersion in the same fixative overnight. Wedges of meridional sections of the trabecular meshwork were post-fixed in 1% osmium tetroxide, block-stained in 2% uranyl acetate, dehydrated and embedded in Spurr embedding medium. Ultrathin sections were stained with potassium permanganate and lead and examined with a JEOL (Peabody, MA, USA) 1200Ex transmission electron microscope.
